A Putnam County high school sophomore was diagnosed with a rare form of lymphoma and is beginning intensive chemotherapy ...

Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and ...

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what ...

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma. It develops when abnormal B cells rapidly accumulate in lymph nodes, causing painless swelling often in the ...

New population studies suggest that tattoos may be associated with a higher risk for lymphoma and skin cancer, although ...

The FDA has cleared BeOne Medicines’ BCL2 blocker sonrotoclax for the treatment of certain patients with mantle cell lymphoma ...

Rylie Kuyper was shocked to learn she had cancer. It still didn’t feel real when she told her family, so she turned to humor, ...

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic ...

Targeted maternal screening could substantially reduce the spread of a virus associated with a rare and fatal malignancy that ...

EZH2 inhibitor tazemetostat (Tazverik) is being withdrawn from global markets ...

What is it: Hodgkin lymphoma is a less common type of lymphoma that often starts in the upper body and is marked by the presence of Reed‑Sternberg cells. Treatment outlook: With modern therapies, ...